Certified by Founder Lodge
Proniras Corporation
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $4,650,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Proniras Corporation is a clinical-stage biotechnology developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders. The Comp
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 02 ,2024 | Series B | $4,650,000 |
Accelerator Life Science Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026)
